SARS-CoV-2 and neurological disorders: the revelance of biomarkers?

被引：1

作者：

Bigot-Corbel, Edith ^{[1
]}

Lanore, Aymeric ^{[2
]}

Raulet, Celia ^{[3
]}

Delorme, Cecile ^{[2
,4
]}

Azulay, Jean-Philippe ^{[5
,6
]}

Lehmann, Sylvain ^{[7
,8
]}

Beaudeux, Jean-Louis ^{[9
]}

Beauvieux, Marie-Christine ^{[10
,11
]}

Sapin, Vincent ^{[12
]}

Peoc'h, Katell ^{[3
,13
]}

Rucheton, Benoit ^{[14
]}

机构：

[1] CHU Nantes, Hop Laennec, Lab Biochim, St Herblain, France

[2] Sorbonne Univ, Hop Pitie Salpetriere, AP HP, Dept Neurol, Paris, France

[3] Hop Bichat Claude Bernard, AP HP, Serv Biochim, Paris, France

[4] Sorbonne Univ, Paris Brain Inst, ICM, INSERM,U1127,CNRS,UMR 7225, Paris, France

[5] Hop La Timone, Serv Neurol & Pathol Mouvement, Ctr Expert Parkinson, Ctr Competences Malad Rares Mouvement & Cognit, Marseille, France

[6] SFN, Marseille, France

[7] CHU, Hop St Eloi, Inst Med Regeneratrice & Biotherapies IRMB, Lab Biochim Proteom Clin,CCBHM, Montpellier, France

[8] Univ Montpellier, Fac Med, INSERM, U1040, Montpellier, France

[9] Hop Necker Enfants Malad, AP HP, Serv Biochim Gen, Paris, France

[10] CHU Bordeaux, Serv Biochim, Bordeaux, France

[11] Univ Bordeaux, CNRS, UM5536, Bordeaux, France

[12] CHU, Serv Biochim & Genet Mol, Clermont Ferrand, France

[13] Univ Paris, UFR Med Xavier Bichat, Paris, France

[14] Sorbonne Univ, Hop Univ Pitie Saipetriere, AP HP, DMU BioGeM,Serv Biochim Metab, Paris, France

来源：

ANNALES DE BIOLOGIE CLINIQUE | 2021年 / 79卷 / 01期

关键词：

SARS-CoV-2; Covid-19; neuroinflammation; neurological impairment; cerebrospinal fluid; biomarkers; INFECTION; COVID-19;

D O I：

10.1684/abc.2021.1622

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

*Soon after the pandemic, numerous publications described cases of neurological disorders associated with the SARS-CoV-2 infection. The range of neurological symptoms is becoming increasingly more extensive as the pandemic progresses. However, it is not yet well established whether the manifestations are due to direct viral damage to the nervous system or indirect consequences of the infection. This review presents an inventory of the biochemical markers studied in the context of neurological disorders related to SARS-CoV-2. By reflecting various physiopathological mechanisms, these biomarkers allow both a better understanding of the pathophysiology of Covid-19 and a contribution to the diagnosis of neurologic troubles; they could participate in the prognostic evaluation of patients.

引用

页码：7 / 16

页数：10

共 50 条

[31] SARS-CoV-2 Infectivity and Neurological Targets in the Brain
Lukiw, Walter J.
Pogue, Aileen
Hill, James M.
[J]. CELLULAR AND MOLECULAR NEUROBIOLOGY, 2022, 42 (01) : 217 - 224
[32] SARS-CoV-2 Infection Leads to Neurological Dysfunction
Acharya, Arpan
Kevadiya, Bhavesh D.
Gendelman, Howard E.
Byrareddy, Siddappa N.
[J]. JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2020, 15 (02) : 167 - 173
[33] Neurological side effects of SARS-CoV-2 vaccinations
Finsterer, Josef
[J]. ACTA NEUROLOGICA SCANDINAVICA, 2022, 145 (01): : 5 - 9
[34] Neurological infection and complications of SARS-CoV-2: A review
Singh, Santosh
Meher, Nikita
Mohammed, Arifullah
Razab, Mohammad Khairul Azhar Abdul
Bhaskar, L. V. K. S.
Nawi, Norazlina Mat
[J]. MEDICINE, 2023, 102 (05) : E30284
[35] Coagulation disorders in SARS-CoV-2 infection
Mihaila, Romeo Gabriel
Mihaila, Marius Dragos
[J]. BIOMEDICAL PAPERS-OLOMOUC, 2020, 164 (03): : 226 - 235
[36] Impact of SARS-CoV-2 on neuropsychiatric disorders
de los Angeles Robinson-Agramonte, Maria
Goncalves, Carlos-Alberto
Noris-Garcia, Elena
Prendes Rivero, Naybi
Lisa Brigida, Anna
Schultz, Stephen
Siniscalco, Dario
Garcia Garcia, Ramiro Jorge
[J]. WORLD JOURNAL OF PSYCHIATRY, 2021, 11 (07): : 347 - 354
[37] Longitudinal response to mRNA SARS-CoV-2 vaccines and breakthrough infection in autoimmune neurological disorders
Giannoccaro, M.
Vacchiano, V.
Leone, M.
Camilli, F.
Zenesini, C.
Gamberini, C.
Panzera, I.
Tappata, M.
Ricciardiello, F.
Furia, A.
Masullo, M.
Morelli, L.
De Marco, G.
Borghi, A.
Salvi, F.
Lugaresi, A.
D'Angelo, R.
Rinaldi, R.
Lazzarotto, T.
Liguori, R.
[J]. EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 226 - 227
[38] Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab
Nytrova, P.
Stastna, D.
Tesar, A.
Menkyova, I.
Posova, H.
Koprivova, H.
Mikulova, V.
Smela, G.
Hrdy, J.
Horakova, D.
Doleckova, K.
Rysankova, I.
Tyblova, M.
[J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 2023, 53 : 117 - 118
[39] Correspondence on functional neurological disorders after COVID-19 and SARS-CoV-2 vaccines
Kleebayoon, Amnuay
Wiwanitkit, Viroj
[J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2023, 94 (09): : 777 - 778
[40] Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab
Nytrova, Petra
Stastna, Dominika
Tesar, Adam
Menkyova, Ingrid
Posova, Helena
Koprivova, Helena
Mikulova, Veronika
Hrdy, Jiri
Smela, Gabriela
Horakova, Dana
Rysankova, Irena
Doleckova, Kristyna
Tyblova, Michaela
[J]. FRONTIERS IN IMMUNOLOGY, 2023, 14

← 1 2 3 4 5 →